Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review

Botulinum toxin type A for the treatment of lower urinary tract disorders

(2012) Teruhiko Yokoyama et al.   INTERNATIONAL JOURNAL OF UROLOGY

Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity

(2012) David Ginsberg et al.   JOURNAL OF UROLOGY

Botulinum toxin: does the black box warning justify change in practice?

(2011) UNNI G NARAYANAN   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy

(2011) STEPHEN J O’FLAHERTY et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity

(2011) A. Conte et al.   EUROPEAN JOURNAL OF NEUROLOGY

Contemporary Management of Lower Urinary Tract Disease With Botulinum Toxin A: A Systematic Review of Botox (OnabotulinumtoxinA) and Dysport (AbobotulinumtoxinA)

(2011) Altaf Mangera et al.   EUROPEAN UROLOGY

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

(2011) Francisco Cruz et al.   EUROPEAN UROLOGY

Terminology for Preparations of Botulinum Neurotoxins

(2011) Alberto Albanese   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of repeated detrusor onabotulinumtoxina injections on bladder and renal function in patients with chronic spinal cord injuries

(2011) Hann-Chorng Kuo et al.   NEUROUROLOGY AND URODYNAMICS

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients

(2011) S. Deffontaines-Rufin et al.   International Braz J Urol

Epidemiology and healthcare utilization of neurogenic bladder patients in a us claims database

(2010) Aubrey Manack et al.   NEUROUROLOGY AND URODYNAMICS

Botulinum Toxin Therapy for Neurogenic Detrusor Overactivity

(2010) Marc C. Smaldone et al.   UROLOGIC CLINICS OF NORTH AMERICA

Patients’ perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury

(2009) Satoshi Hori et al.   BJU INTERNATIONAL

Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?

(2009) Carlos Martins da Silva et al.   CURRENT OPINION IN UROLOGY

Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder

(2009) Ana Coelho et al.   EUROPEAN UROLOGY

Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery

(2009) Michael B. Chancellor   INTERNATIONAL UROLOGY AND NEPHROLOGY

Cost-Effectiveness of Botulinum Toxin A Versus Anticholinergic Medications for Idiopathic Urge Incontinence

(2009) Jennifer M. Wu et al.   JOURNAL OF UROLOGY

Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

(2009) P. Abrams et al.   NEUROUROLOGY AND URODYNAMICS

Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX®) therapy in Germany

(2009) Björn Wefer et al.   WORLD JOURNAL OF UROLOGY

The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study

(2008) Karin S. Coyne et al.   BJU INTERNATIONAL

Histological Changes in the Urothelium and Suburothelium of Human Overactive Bladder following Intradetrusor Injections of Botulinum Neurotoxin Type A for the Treatment of Neurogenic or Idiopathic Detrusor Overactivity

(2008) Apostolos Apostolidis et al.   EUROPEAN UROLOGY

Six-Year Follow-Up of Botulinum Toxin A Intradetrusorial Injections in Patients with Refractory Neurogenic Detrusor Overactivity: Clinical and Urodynamic Results

(2008) Antonella Giannantoni et al.   EUROPEAN UROLOGY

RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOMES AND MEDICAL CARE OF PATIENTS WITH NEUROGENIC DETRUSOR OVER ACTIVITY (NDO) RECEIVING BOTOX® THERAPY

(2008) S. Boy et al.   EUROPEAN UROLOGY SUPPLEMENTS

Botulinum Toxin A Detrusor Injections in Patients with Neurogenic Detrusor Overactivity Significantly Decrease the Incidence of Symptomatic Urinary Tract Infections

(2007) Xavier Gamé et al.   EUROPEAN UROLOGY

Neurogenic Detrusor Overactivity Treated with English Botulinum Toxin A: 8-Year Experience of One Single Centre

(2007) Giulio Del Popolo et al.   EUROPEAN UROLOGY

Botulinum Toxin A (Botox®) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review

(2007) Gilles Karsenty et al.   EUROPEAN UROLOGY